Literature DB >> 17847769

Successful management of a pregnant woman with HELLP syndrome, pulmonary edema, postpartum hemorrhage and acute renal failure, using early hemodialysis, intravenous immunoglobulin and noninvasive monitoring: a case report.

Fu-Nan Cho1, San-Nung Chen, Yuen-Yee Kan, Te-Ching Lee, Jyh-Seng Wang.   

Abstract

BACKGROUND: HELLP syndrome (hemolysis, elevated liver enzymes, low platelets) with medical complications is a major cause of maternal mortality in pregnancy. A vicious cycle may occur without expeditious delivery and proper management. CASE: A woman with severe HELLP syndrome, hemolytic renal failure, pulmonary edema and postpartum hemorrhage was successfully managed using early hemodialysis, intravenous immunoglobulin (IVIG) and noninvasive hemodynamic monitoring.
CONCLUSION: Pulmonary edema is easily managed by early hemodialysis. IVIG may be a viable treatment for thrombocytopenia and hemolysis but can induce reversible interstitial nephritis and membranous glomerulonephritis.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17847769

Source DB:  PubMed          Journal:  J Reprod Med        ISSN: 0024-7758            Impact factor:   0.142


  3 in total

1.  Intravenous immunoglobulin prevents murine antibody-mediated acute lung injury at the level of neutrophil reactive oxygen species (ROS) production.

Authors:  John W Semple; Michael Kim; Jing Hou; Mark McVey; Young Jin Lee; Arata Tabuchi; Wolfgang M Kuebler; Zhong-Wei Chai; Alan H Lazarus
Journal:  PLoS One       Date:  2012-02-17       Impact factor: 3.240

2.  Role and mechanism of AT1-AA in the pathogenesis of HELLP syndrome.

Authors:  Shurui Bu; Yuxian Wang; Shuqing Sun; Yanqian Zheng; Zhu Jin; Jianming Zhi
Journal:  Sci Rep       Date:  2018-01-10       Impact factor: 4.379

Review 3.  The HELLP syndrome: clinical issues and management. A Review.

Authors:  Kjell Haram; Einar Svendsen; Ulrich Abildgaard
Journal:  BMC Pregnancy Childbirth       Date:  2009-02-26       Impact factor: 3.007

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.